Adalimumab 43835-0033-01
- Manufacturer
- Novo Nordisk Production Belgium Sa
- Dosage Form
- Injection
- Product Type
- Drug For Further Processing
- Marketing Start
- January 1, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab-Bwwd | 100 mg/mL |
Selected Package
43835-0033-01Selected9 BOX in 1 CONTAINER (43835-0033-1) / 160 SYRINGE in 1 BOX / .4 mL in 1 SYRINGE